Border Crossing and Situation on Problems of Medicine and Health Products along Thailand’s Borders – the Case of Corticosteroids
Main Article Content
Abstract
The distribution and usage of high-risk corticosteroids along Thailand's border areas reveal vulnerabilities in regulatory systems under the complex borderland contexts, affecting public health nationwide. This study aims to understand these phenomena to highlight structural realities and propose appropriate community-level and policy-level solutions. Methods: This qualitative study collected data through literature reviews, field notes, in-depth interviews, and participant observation. The research spanned Thailand's border provinces with Laos, Cambodia, Myanmar, and Malaysia, involving health officials, public health personnel, migrant workers, local vendors, and patients. Data underwent triangulation and thematic analysis, with insights validated through expert consultations between October 2024 and April 2025. Results: Thailand’s border regions face significant challenges related to the smuggling of unregulated and substandard pharmaceuticals, notably health products containing banned substances such as Dexamethasone. These findings underscore inadequacies in regulatory mechanisms, evident in all Thai border areas despite existing checkpoints. Border areas serve as hubs for medication access among local populations and migrant workers who lack formal health coverage due to systemic inequalities in neighboring countries. This has led to reliance on purchasing medicines from local vendors and markets, with many utilizing informal ‘YA - CHUD’ (a combination of different drugs in the form of a capsule or tablet and packed in small plastic bags) or counterfeit drugs with temporary efficacy. Overuse of certain drugs, such as Lincomycin injections at clinics, has also been observed. Conclusion: The Landscape of border medicine situation along Thailand’s borders highlights critical gaps in regulatory frameworks, particularly for high-risk drugs. Addressing these issues requires an understanding of the informal and pragmatic governance evident in these areas, where illegal but socially accepted practices persist alongside the transboundary movement of people, goods, and cultural exchanges. Recommendations include improving regulatory processes, leveraging surveillance technologies, fostering international collaboration, and empowering border-area volunteers to enhance public health and state security sustainably.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
In the case that some parts are used by others The author must Confirm that obtaining permission to use some of the original authors. And must attach evidence That the permission has been included
References
Channel News Asia. Potent medicinal ingredients, banned substance found in five health products: HSA [Internet]. 2022 Jan 17 [cited 2024 Dec 5]. Available from: https://www.channelnewsasia.com/singapore/potent-medicinal-ingredients-banned-substance-found-five-health-products-hsa-alert-2407166
Deputy police chief leads warehouse raid at Mae Sai border, busts deadly slimming product network and blocks sibutramine trafficking route. Manager Online [Internet]. 2019 Jul 14 [cited 2025 Feb 3]. Available from: https://mgronline.com/local/detail/9620000067025
Department of Health, Hong Kong SAR. Public urged not to buy or use slimming product “Marina Slimming Coffee” [Internet]. 2012 Apr 5 [cited 2024 Nov 22]. Available from: https://www.dh.gov.hk/english/press/2012/120405.html
Drug System Monitoring and Development Academic Center. Border drug system problem management [Internet]. 2024 [cited 2025 Jan 8]. Available from: http://www.thaidrugwatch.org/download/series/series55.pdf
Drug System Monitoring and Development Academic Center. Dangerous border drugs creeping to your home [Internet]. 2016 [cited 2024 Nov 11]. Available from: http://www.thaidrugwatch.org/download/series/series31.pdf
Duangtip H. Problems and development guidelines for surveillance of premises and products: Case study on the spread of steroid tablets. Nonthaburi: FDA; 1996.
Food and Drug Department, Ministry of Health, Lao PDR. Notification of dexamethasone and prednisolone medicines does not guarantee the quality and risks circulating on the market [Internet]. 2016 May 25 [cited 2024 Dec 27]. Available from: http://www.fdd.gov.la/download/documents/2018-01-14_113606pm_Dexamethasone_and_Prednisolone.pdf
Food and Drug Department, Ministry of Health, Lao PDR. Notification of Dexamethasone and Prednisolone medicines does not guarantee the quality and risks circulating on the market [Internet]. 2019 [cited 2024 Nov 16]. Available from: http://www.fdd.gov.la/download/documents/2018-01-14_113606pm_Dexamethasone_and_Prednisolone.pdf
Ministry of Health, Brunei Darussalam. Four types of health products and one type of cosmetic found to be adulterated with undeclared, potent western medicine [Internet]. 2018 Mar 15 [cited 2024 Dec 4]. Available from: https://www.facebook.com/share/p/1BcxgsLqpZ/
Ministry of Health, Brunei Darussalam. MOH finds highly potent steroid in “Dexteem Plus” [Internet]. 2018 Aug 30 [cited 2024 Dec 4]. Available from: https://www.facebook.com/share/p/14yKEXkZj8/
Ministry of Health, Brunei Darussalam. The Ministry of Health (MoH) has issued a public alert regarding the health product Bi Shu Ning. Borneo Bulletin [Internet]. 2024 Oct 3 [cited 2024 Dec 6]. Available from: https://borneobulletin.com.bn/adulterated-health-product-alert/
National Health Assembly Documentation. Steroid management threatening Thai health [Internet]. 2014 [cited 2025 Feb 8]. Available from: http://www.samatcha.org/nha/cms/files/menu_content_files/7/40/111/129/129_20141112110650.pdf
National Pharmaceutical Regulatory Agency (NPRA), Malaysia. Majun Burung Unta: Warning to the Public Regarding the Use of Unregistered Products [Internet]. 2014 Jul 14 [cited 2024 Dec 3]. Available from: https://npra.gov.my/index.php/en/component/content/article/41-english/press-release/press-release-2014/711-majun-burung-unta-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar.html?Itemid=1391
National Pharmaceutical Regulatory Agency (NPRA), Malaysia. Majun Taufiq Dua Istimewa: Warning to the Public Regarding the Use of Unregistered Products [Internet]. 2013 Nov 8 [cited 2024 Dec 5]. Available from: https://npra.gov.my/index.php/en/component/content/article/42-english/press-release/press-release-2013/738-majun-taufiq-dua-istimewa-amaran-kepada-orang-awam-mengenai-pengambilan-produk-tidak-berdaftar.html?Itemid=1391
Panuchot T, et al. Don’t let steroids go unpunished. Drug System Monitoring and Development Centre. 2012 Aug; p.3.
Supanai P. Development project for surveillance mechanisms of steroid-adulterated health products in Northeast Thailand 2014. Consumer Protection Network and Steroid Management Network under FDA support. Drug System Monitoring and Development Centre; 2014.